Evidence map›Paper›PMID 35215134›Full record

ArticlePathogens (Basel, Switzerland)2022

The Antimicrobial Properties of Poplar and Aspen-Poplar Propolises and Their Active Components against Selected Microorganisms, including

Jarosław Widelski, Piotr Okińczyc, Emil Paluch, Tomasz Mroczek, Jakub Szperlik, Magdalena Żuk, Zbigniew Sroka, Zuriyadda Sakipova, Ioanna Chinou, Krystyna Skalicka-Woźniak and 2 more

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 20 citations in OpenAlex.

  1. PeerJ · 2026
    Article
  2. Review
  3. Article
  4. The Antimicrobial Effect ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Article
  7. The effects and mechanisms of natural products onFrontiers in cellular and infection microbiology · 2024
    Review
  8. Review
  9. Article
  10. Probiotics and autoprobiotics for treatment ofWorld journal of clinical cases · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Brazilian Red Propolis Presents Promising Anti-Molecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Jarosław WidelskiDepartment of Pharmacognosy with the Medicinal Plant Garden, Medical University of Lublin, 20-093 Lublin, Poland.
Piotr OkińczycDepartment of Pharmacognosy and Herbal Medicines, Wrocław Medical University, 50-556 Wroclaw, Poland.ORCID 0000-0001-5795-8605
Emil PaluchDepartment of Microbiology, Faculty of Medicine, Wrocław Medical University, 50-376 Wroclaw, Poland.ORCID 0000-0002-3549-6136
Tomasz MroczekDepartment of Chemistry of Natural Products, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0002-5267-7182
Jakub SzperlikFaculty of Biological Sciences, Botanical Garden, Laboratory of Tissue Culture, University of Wrocław, 50-525 Wroclaw, Poland.ORCID 0000-0001-5226-2756
Magdalena ŻukFaculty of Biotechnology, Wrocław University, 51-148 Wroclaw, Poland.ORCID 0000-0003-3343-9303
Zbigniew SrokaDepartment of Pharmacognosy and Herbal Medicines, Wrocław Medical University, 50-556 Wroclaw, Poland.ORCID 0000-0001-6618-017X
Zuriyadda SakipovaSchool of Pharmacy, S.D. Asfendiyarov Kazakh National Medical University, Almaty 050000, Kazakhstan.
Ioanna ChinouDivision of Pharmacognosy and Chemistry of Natural Products, Department of Pharmacy, National and Kapodistrian University of Athens, 15771 Athens, Greece.
Krystyna Skalicka-WoźniakDepartment of Chemistry of Natural Products, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0002-9313-5929
Anna MalmDepartment of Pharmaceutical Microbiology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0003-1503-7634
Izabela Korona-GłowniakDepartment of Pharmaceutical Microbiology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0003-1634-0387
Medical University of Lublin · PLWroclaw Medical University · PLUniversity of Wrocław · PLKazakh National Medical University · KZNational and Kapodistrian University of Athens · GR

Funding

the National Centre of Science, Poland (NCN 2017/25/B/NZ9/01060Wroclaw Medical University STATUTORY RESEARCH SUBZ.A130.22.010 AND SUB.D110.21.101
6 · The paper itself

Abstract

There is a noticeable interest in alternative therapies where the outcome is the eradication of the Gram-negative bacterium,

Indexed as

Bacillus cereusEnterococcus faecalisgalanginHelicobacter pylorihierarchical fuzzy clustering analysisLC-MSMBCMICMicrococcus luteusPCApinocembrinprincipal component analysispropolisStaphylococcus aureusStaphylococcus epidermidis

Identifiers

PMID35215134
PMCPMC8875431
OpenAlexW4210495132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.